Based on the price of a share on April 9, the dividend yield reaches 5.6%, according to ZF calculations.
The company’s Board of Directors proposed its shareholders to approve dividends of RON20 million, which represent the difference between the distributed profit, in the amount of RON30.8 million, and other reserves from profit, of RON10.7 million.
Antibiotice is 53% owned by the Romanian state and 18.8% held by regional investment fund SIF Oltenia (SIF5.RO). Thus, the Health Ministry will receive RON10.6 million and SIF5 will get the remainder.
The company’s shares have been trading up 4.3% since the start of 2020, amid deals worth RON2.5 million, securing it a market capitalization of RON355.8 million.